Treating depression during COVID-19: Considerations for psychological and psychiatric treatment

Presented by Rachel Leonard, PhD, LP, and Christopher Lowden, MD

View slides from this presentation

Review behavioral activation theory and pharmacotherapy for depression, and gain an understanding of the benefits of a combined approach, in part one of this webinar series. Time will also be spent identifying necessary modifications for pharmacotherapy during COVID-19 and adaptations for behavioral activation, which are necessary when treatment is provided via telehealth.

 

Related resources

#
Rising Above Mood Disorders: Meg's Story
Learn more
#
Creating a new normal for kids during COVID-19
Dr. Amanda Heins explains how creating structure, predictability, and…
Learn more
#
What you need to know about suicide that could save a life
Rogers' experts share common misconceptions surrounding suicide and the…
Learn more

Call 800-767-4411 or go to rogersbh.org to request a free screening.